-
Accelerating progress for adenoid cystic carcinoma
Nearly two decades ago, Marnie Kaufman was diagnosed with adenoid cystic carcinoma (ACC), a rare type of cancer most commonly arising in the salivary glands. Shortly thereafter, she and her husband, Jeff, established the Adenoid Cystic Carcinoma Research Foundation.
-
METAvivor advances metastatic breast cancer research
METAvivor, a non-profit organization that funds important research for stage IV metastatic breast cancer (MBC), has awarded research grants totaling $700,000 to three Dana-Farber faculty members
-
New fellowships in pediatric brain cancer research
The ChadTough Defeat DIPG Foundation began as two organizations founded by Jason and Tammi Carr and Mark and Jenny Mosier.
-
Defeating advanced and aggressive kidney cancers
The Kidney Cancer Association (KCA) has made $650,000 in grants to three Dana-Farber researchers who are unlocking the molecular mechanisms of a disease that will be diagnosed in nearly 82,000 U.S. residents this year and claim the lives of more than 14,000.
-
Dana-Farber’s B.A.A. Half team runs 13.1 miles to defy cancer
The B.A.A. Half Marathon® returned to Boston’s Emerald Necklace on Sunday, Nov. 13, 2022, in person for the first time since 2019. Dana-Farber’s 2022 B.A.A. Half team included 485 team members running 13.1 miles, both in-person and virtually, to support Dana-Farber’s commitment to groundbreaking research and quality patient care.
-
Grants support innovations in pediatric cancer research
For over 12 years, grants awarded by Hyundai Hope On Wheels® totaling over $5.5 million have supported Dana-Farber investigators and their research to further discovery, leverage new technologies, and revolutionize treatment for pediatric patients everywhere.
-
Rasmussen Family funds research into underlying causes of colorectal cancer
Anna and Neil Rasmussen are no strangers to medical research in the quest to find answers to chronic illness—one of their children had been living with ulcerative colitis since she was seven years old.
-
IMS grants drive innovative multiple myeloma research
The International Myeloma Society (IMS) recently awarded three Dana-Farber scientists grants totaling $525,000 to promote research on the blood cancer multiple myeloma.
-
Gift to ovarian cancer inspired by story of research
In early 2022, Dr. Jean Kasmer read a story in Impact about an ovarian cancer survivor who gave to support the research of Ursula Matulonis, MD, chief of the division of Gynecologic Oncology and the Brock-Wilson Family Chair at Dana-Farber.
-
Johnston gift paves the way for a novel ovarian cancer clinical trial
Debbie Johnston is dedicated to supporting causes that are close to her heart, and Dana-Farber Cancer Institute’s ovarian cancer research is one such cause.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.